Status:
UNKNOWN
A Prospective Study to Investigate Contact Sensitization Using Classic and Machine Learning Techniques
Lead Sponsor:
Andreas Syggros Hospital of Venereal and Dermatological Diseases
Conditions:
Allergic Contact Dermatitis
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this study is to look into the patterns of sensitization to figure out how allergic contact dermatitis (ACD), individual susceptibility, and patient characteristics are connected. The join...
Eligibility Criteria
Inclusion
- \-
- Eligible patients were adults diagnosed with dermatitis who had a positive patch test result on the chemical panel of Baseline Series of Allergens.
Exclusion
- \-
- Although there is no consensus for the definitive exclusion criteria from a patch testing, most studies agree that the chronic use of anti-inflammatory treatments, corticosteroids, and cyclosporine, high UV exposure and other chronic dermatoses are factors that might produce false- positive or false- negative results and thus should be avoided.
Key Trial Info
Start Date :
June 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 30 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05991674
Start Date
June 30 2023
End Date
October 30 2023
Last Update
August 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Georgia Gogkla
Athens, Attica, Greece, 11621